Publication

A light-responsive liposomal agent for MRI contrast enhancement and monitoring of cargo delivery

Reeßing, F., Stuart, M. C. A., Samplonius, D. F., Dierckx, R. A. J. O., Feringa, B. L., Helfrich, W. & Szymanski, W., 16-Sep-2019, In : Chemical communications (Cambridge, England). 55, 72, p. 10784-10787 4 p.

Research output: Contribution to journalArticleAcademicpeer-review

APA

Reeßing, F., Stuart, M. C. A., Samplonius, D. F., Dierckx, R. A. J. O., Feringa, B. L., Helfrich, W., & Szymanski, W. (2019). A light-responsive liposomal agent for MRI contrast enhancement and monitoring of cargo delivery. Chemical communications (Cambridge, England), 55(72), 10784-10787. https://doi.org/10.1039/c9cc05516a

Author

Reeßing, F ; Stuart, M C A ; Samplonius, D F ; Dierckx, R A J O ; Feringa, B L ; Helfrich, W ; Szymanski, W. / A light-responsive liposomal agent for MRI contrast enhancement and monitoring of cargo delivery. In: Chemical communications (Cambridge, England). 2019 ; Vol. 55, No. 72. pp. 10784-10787.

Harvard

Reeßing, F, Stuart, MCA, Samplonius, DF, Dierckx, RAJO, Feringa, BL, Helfrich, W & Szymanski, W 2019, 'A light-responsive liposomal agent for MRI contrast enhancement and monitoring of cargo delivery', Chemical communications (Cambridge, England), vol. 55, no. 72, pp. 10784-10787. https://doi.org/10.1039/c9cc05516a

Standard

A light-responsive liposomal agent for MRI contrast enhancement and monitoring of cargo delivery. / Reeßing, F; Stuart, M C A; Samplonius, D F; Dierckx, R A J O; Feringa, B L; Helfrich, W; Szymanski, W.

In: Chemical communications (Cambridge, England), Vol. 55, No. 72, 16.09.2019, p. 10784-10787.

Research output: Contribution to journalArticleAcademicpeer-review

Vancouver

Reeßing F, Stuart MCA, Samplonius DF, Dierckx RAJO, Feringa BL, Helfrich W et al. A light-responsive liposomal agent for MRI contrast enhancement and monitoring of cargo delivery. Chemical communications (Cambridge, England). 2019 Sep 16;55(72):10784-10787. https://doi.org/10.1039/c9cc05516a


BibTeX

@article{d8b7c04a59364ab8957fa1061f0d73f1,
title = "A light-responsive liposomal agent for MRI contrast enhancement and monitoring of cargo delivery",
abstract = "Medical magnetic resonance imaging (MRI) produces high-resolution anatomical images of the human body, but has limited capacity to provide useful molecular information. The light-responsive, liposomal MRI contrast agent described herein could be used to provide an intrinsic theranostic aspect to MRI and enable tracking the distribution and cargo release of drug delivery systems upon light-triggered activation.",
author = "F Ree{\ss}ing and Stuart, {M C A} and Samplonius, {D F} and Dierckx, {R A J O} and Feringa, {B L} and W Helfrich and W Szymanski",
year = "2019",
month = "9",
day = "16",
doi = "10.1039/c9cc05516a",
language = "English",
volume = "55",
pages = "10784--10787",
journal = "Chemical Communications (Cambridge, United Kingdom)",
issn = "1359-7345",
publisher = "ROYAL SOC CHEMISTRY",
number = "72",

}

RIS

TY - JOUR

T1 - A light-responsive liposomal agent for MRI contrast enhancement and monitoring of cargo delivery

AU - Reeßing, F

AU - Stuart, M C A

AU - Samplonius, D F

AU - Dierckx, R A J O

AU - Feringa, B L

AU - Helfrich, W

AU - Szymanski, W

PY - 2019/9/16

Y1 - 2019/9/16

N2 - Medical magnetic resonance imaging (MRI) produces high-resolution anatomical images of the human body, but has limited capacity to provide useful molecular information. The light-responsive, liposomal MRI contrast agent described herein could be used to provide an intrinsic theranostic aspect to MRI and enable tracking the distribution and cargo release of drug delivery systems upon light-triggered activation.

AB - Medical magnetic resonance imaging (MRI) produces high-resolution anatomical images of the human body, but has limited capacity to provide useful molecular information. The light-responsive, liposomal MRI contrast agent described herein could be used to provide an intrinsic theranostic aspect to MRI and enable tracking the distribution and cargo release of drug delivery systems upon light-triggered activation.

U2 - 10.1039/c9cc05516a

DO - 10.1039/c9cc05516a

M3 - Article

VL - 55

SP - 10784

EP - 10787

JO - Chemical Communications (Cambridge, United Kingdom)

JF - Chemical Communications (Cambridge, United Kingdom)

SN - 1359-7345

IS - 72

ER -

ID: 95006295